Literature DB >> 8577267

Immunological characterization of the neurotoxin produced by Clostridium botulinum type A associated with infant botulism in Japan.

S Kozaki1, S Nakaue, Y Kamata.   

Abstract

The neurotoxin associated with type A infant botulism in Japan shows different antigenic properties from those produced by authentic strains. The monoclonal antibodies recognizing the light chain reacted to both neurotoxins, whereas half the antibodies recognizing the heavy chain reacted specifically to the respective neurotoxin. Each neurotoxin showed its own manner of binding to brain synaptosomes. These results indicate that the distinguishable characteristics are ascribable to the heavy chain but not to the light chain. In both neurotoxins, an epitope recognized by the monoclonal antibody that reacts to the light chain and neutralizes the toxin was found to be very close to the amino-terminal half (H-1 fragment) of the heavy chain. This may support the hypothesis that the H-1 fragment functions in the transport of the light chain in the target cell.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8577267     DOI: 10.1111/j.1348-0421.1995.tb03269.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  17 in total

1.  Mass Spectrometric Identification and Differentiation of Botulinum Neurotoxins through Toxin Proteomics.

Authors:  Suzanne R Kalb; John R Barr
Journal:  Rev Anal Chem       Date:  2013-08       Impact factor: 3.067

2.  Genetic diversity among Botulinum Neurotoxin-producing clostridial strains.

Authors:  K K Hill; T J Smith; C H Helma; L O Ticknor; B T Foley; R T Svensson; J L Brown; E A Johnson; L A Smith; R T Okinaka; P J Jackson; J D Marks
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

3.  Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.

Authors:  T J Smith; J Lou; I N Geren; C M Forsyth; R Tsai; S L Laporte; W H Tepp; M Bradshaw; E A Johnson; L A Smith; J D Marks
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Genetic characterization of Clostridium botulinum associated with type B infant botulism in Japan.

Authors:  Kaoru Umeda; Yoshiyuki Seto; Tomoko Kohda; Masafumi Mukamoto; Shunji Kozaki
Journal:  J Clin Microbiol       Date:  2009-07-01       Impact factor: 5.948

5.  Antibody mapping to domains of botulinum neurotoxin serotype A in the complexed and uncomplexed forms.

Authors:  F Chen; G M Kuziemko; P Amersdorfer; C Wong; J D Marks; R C Stevens
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

6.  Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1.

Authors:  Christina L Pier; Chen Chen; William H Tepp; Guangyun Lin; Kim D Janda; Joseph T Barbieri; Sabine Pellett; Eric A Johnson
Journal:  FEBS Lett       Date:  2010-11-30       Impact factor: 4.124

7.  Proposed BoNT/A and /B Peptide Substrates Cannot Detect Multiple Subtypes in the Endopep-MS Assay.

Authors:  Suzanne R Kalb; Jakub Baudys; Kaitlyn Kiernan; Dongxia Wang; François Becher; John R Barr
Journal:  J Anal Toxicol       Date:  2020-03-07       Impact factor: 3.367

8.  Differentiation of the gene clusters encoding botulinum neurotoxin type A complexes in Clostridium botulinum type A, Ab, and A(B) strains.

Authors:  Giovanna Franciosa; Francesca Floridi; Antonella Maugliani; Paolo Aureli
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

9.  Phylogenetic analysis of Clostridium botulinum type A by multi-locus sequence typing.

Authors:  Mark J Jacobson; Guangyun Lin; Thomas S Whittam; Eric A Johnson
Journal:  Microbiology       Date:  2008-08       Impact factor: 2.777

10.  Characterization of Clostridium botulinum type B neurotoxin associated with infant botulism in japan.

Authors:  S Kozaki; Y Kamata; T Nishiki; H Kakinuma; H Maruyama; H Takahashi; T Karasawa; K Yamakawa; S Nakamura
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.